Myoscience Focused Cold Therapy Device Receives FDA Clearance

Share on Facebook
Myoscience in Redwood City, Calif., a medical device company, announced that the newest generation of its patented device technology has received FDA clearance for the treatment of pain.   

Focused Cold Therapy — the patented technology — delivers cold to targeted nerves. The cold induces a hibernating state and achieves an immediate result.

The hand-held device allows for treatment of pain without systemic side effects or addictive potential.

More Articles on Pain Management:

SPR Therapeutics Raise $5M For Commercializing Pain Therapies
Study: Joint Disorders, Back Pain Among Top Reasons People Visit Physicians
Study: Vitamin D May Not Prevent Osteoarthritis


© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.